Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Clinical trial NCT02430363 · UNKNOWN

Trial details

NCT number

NCT02430363

Sponsor

Medical Research Council

Status

UNKNOWN

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2013-03-01

Primary completion

2016-01-01

Enrollment

58

View on ClinicalTrials.gov